Stocks · US
ZBH
XNYS
Zimmer Biomet Holdings, Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E21.65x
P/B1.38x
P/S2.05x
EPS$4.23
ROE6.39%
ROA3.54%
Dividend yield1.08%
EV/EBITDA9.90x
Debt/Equity0.59
Free cash flow$1.1B
Returns and 52-week range
1W-1.82%
1M-8.56%
3M+2.42%
6M-1.88%
1Y-11.01%
YTD-0.38%
52W high$106.88
52W low$79.12
From 52W high-16.09%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Revvity, Inc. | $17.6B | 73.92 | 2.43 | +17.72% |
| Medpace Holdings, Inc. Common Stock | $17.3B | 35.24 | 39.92 | +1.96% |
| 비아트리스 | $20.2B | — | 1.42 | +3.91% |
| Jazz Pharmaceuticals, Inc. | $15.3B | 16.29 | 3.19 | -6.25% |
| STERIS plc | $20.6B | 25.56 | 2.86 | -7.10% |
| 템퍼스 AI | $15.2B | — | 34.09 | +11.39% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.